Sankey It
Loading...
Pfizer Inc. FY2021 income statement | Sankey It
Sankey It · PFE
Pfizer Inc. FY2021 income statement
USD · fiscal year ended 2021-12-31
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Pfizer Inc. FY2021 income statement
Flow diagram with 8 nodes and 7 flows for Pfizer Inc. FY2021 income statement. Values: Biopharma Segment US$79.6B, Revenue US$81.3B, Cost of Revenue US$34.4B, Gross Profit US$46.9B, Operating Expenses US$26.1B, Operating Income US$20.8B, Tax US$1.9B, Net Income US$22.1B.
Biopharma Segment
US$79.6B
98% of revenue
Revenue
US$81.3B
Cost of Revenue
(US$34.4B)
42% of revenue
Gross Profit
US$46.9B
58% margin
Operating Expenses
(US$26.1B)
32% of revenue
Operating Income
US$20.8B
26% margin
Tax
(US$1.9B)
2% of revenue
Net Income
US$22.1B
27% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen